# Blend to Limit Oxygen in ECMO: A Randomised Controlled Registry Trial

> **NCT03841084** · PHASE2 · COMPLETED · sponsor: **Australian and New Zealand Intensive Care Research Centre** · enrollment: 300 (actual)

## Conditions studied

- Cardiac Failure
- Critical Illness

## Interventions

- **DRUG:** Oxygen

## Key facts

- **NCT ID:** NCT03841084
- **Lead sponsor:** Australian and New Zealand Intensive Care Research Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-18
- **Primary completion:** 2023-06-03
- **Final completion:** 2023-07-01
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2024-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03841084

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03841084, "Blend to Limit Oxygen in ECMO: A Randomised Controlled Registry Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03841084. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*